Error message

The page you requested does not exist. For your convenience, a search was performed using the query events thu 10 jan 0930 scientists guide art radiation therapy neurosurgery oncologist these talks.

Search results

  1. Dr Catherine Lindon

    ... role of substrate proteolysis in the precisely coordinated events giving rise to two daughter cells at the end of mitosis. The Aurora ...

  2. Dr Athena Matakidou

    ... modify the mouse renal apithelium and replicate the genetic events observed in human renal cell carcinoma. The development of reproducible ...

  3. Dr Mariann Bienz

    ... cell compartment. Our aim is to understand the molecular events underlying Wnt signal transduction. We focus on positively-acting ...

  4. Dr Dario Bressan

    ... for the spatial and temporal control of biological events in vivo. Specifically, I am using photochemically caged ligands and ...

  5. Dr Frank McCaughan

    My research is focused on understanding the early driver events that are critical to the development of squamous lung cancer (SQC) and ...

  6. Professor Gillian Murphy

    ... by trafficking which allows specific localisation in events such as cell invasion. The identification of the importance of specific ...

  7. Dr James Nathan

    Cellular mechanisms of oxygen and metabolite sensing: ...

  8. Dr James Rudd

    ... arteries as a predictor of plaque rupture and clinical events. Additionally, I use non-invasive imaging methods such as PET, MRI and ...

  9. Ms Paola Marco

    ... The inhibitor can be washed out, allowing us to study events in a more flexible way. I will introduce these mutants in RPE cells to ...

  10. Dr Marisa Segal

    ... morphogenesis in S. cerevisiae we have focused on the events that determine SPB asymmetry or spindle polarity, i.e. the mechanisms ...

  11. Dr David Gilligan

    David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...

  12. Mr David Thurtle

    Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer

  13. Professor David Glover

    Our laboratory studies the regulation of progression through mitosis and meiosis in animal cells. The high degree of evolutionary conservation of these regulatory mechanisms means that findings in model organisms are readily applicable to human cells....

  14. Dr Roisin Owens

    Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...

  15. Mr Thierry Lefebvre

    Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...

  16. Professor Walid Khaled

    My laboratory works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on how the cell of origin affects the differentiation trajectory of nascent tumour cells and dictates changes...

  17. Dr Anita Chandra

  18. Professor Antonis Antoniou

    ... are used in clinical practice. I have a research group of 10 which focuses on two broad areas: - the development and evaluation of risk ...

  19. Dr Adrian Ionescu

    ... wall motion and magnetic storage technology. Over the last 10 years I have built up a strong track record with international recognition ...

  20. Professor Andrew Flewitt

    I work in large area electronics and MEMS devices, with a particular focus on acoustic wave devices using thin film piezoelectrics. There are two applications of these. Surface acoustic wave (SAW) devices can be used to make microfluidic pumps without...

  21. Dr Allanah Barker

  22. Dr Andrew King

  23. Dr Anna Godfrey

  24. Professor Anthony Davenport

    Our research group focuses on understanding the role of G-protein-coupled receptors (GPCRs, targets for about ~50% of current drugs) together with their transmitters in humans. We use in vitro pharmacology and in vivo imaging using positron emission...

  25. Dr Tony Jackson

    Proteomic approaches to plasma-membrane assemblies: Membrane proteins cluster together selectively as spatially-restricted, functionally integrated complexes. This can play an important role in many biological processes, including signal transduction....

  26. Professor Tony Green

    Tony Green is Professor of Haemato-oncology in the University of Cambridge and honorary Consultant Haematologist at Addenbrookes Hospital. He was appointed Head of the University Department of Haematology (2000-2020), and in 2016 was appointed Director...

  27. Dr Alejandra Bruna

    We aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in the regulation of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the...

  28. Dr Danish Mazhar

    Dr Mazhar was a Medical Undergraduate at the University of Oxford and completed his Clinical Training in London. He undertook Specialist Training in Medical Oncology at the Hammersmith and Charing Cross Hospitals in London. He was awarded a PhD by...

  29. Mr Giuseppe Aresu

    Mr Aresu is a Consultant Thoracic Surgeon at the Royal Papworth Hospital. He undertook his Cardiothoracic specialist training in Padua, Udine (Italy) and in Bristol (UK). In November 2011 he started working as consultant thoracic surgeon in Udine where...

  30. Mrs Jane Bushen

  31. Mrs Jane Lichfield

  32. Dr Jane Dobson

    As a Veterinary Oncologist, I am interested in many aspects of cancer including diagnostic methods and treatment of commonly occuring cancers in animals eg lymphoma and osteosarcoma. Animals cancer patients could provide an excellent model for...

  33. Dr Janet Maguire

  34. Dr Jan Czarnecki

  35. Dr Ljiljana Fruk

  36. Dr Anna Piskorz

    ... PHL-093 Toronto, OZM-061 Toronto) and collaborate with scientists from other research centres: University of Calgary (Canada), NKI ...

  37. Professor Eamonn Maher

    ... in research training for clinician and non-clinician scientists and had supervised more than 25 PhD or MD students to completion. ...

  38. Professor Grant Stewart

    ... of over 40 clinicians, translational researchers and basic scientists across the Cambridge Biomedical Campus with a shared interest in ...

  39. Dr Paul Lyons

    ... Disease. This is a collaboration between clinicians, basic scientists and bioinformaticians that aims to apply expression profiling to the ...

  40. Professor Vincent Gnanapragasam

    ... urology trials. He has also established links with STEM scientists to develop a number of innovations including biosensors for cancer ...

  41. Dr Andrew Gee

    Since 1995, I have been working on technical aspects of clinical ultrasonic imaging, with particular emphasis on three-dimensional imaging and elastography (stiffness imaging). Along with Richard Prager and Graham Treece, I lead the Medical Imaging...

  42. Mr Angelos Kolias

    Angelos Kolias is a Clinical Senior Lecturer and Consultant Neurosurgeon in the Department of Clinical Neurosciences, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK. He also holds an adjunct Professorship at Humanitas University,...

  43. Miss Nicola Fearnhead

    Miss Nicola Fearnhead has been a Consultant Colorectal Surgeon at Addenbrooke's Hospital, Cambridge since 2006. She is a graduate of Pembroke College, Cambridge and Merton College, Oxford where she was a Rhodes Scholar. Surgical training was...

  44. Dr Gaia Schiavon

    ... in clinical trials, disease linkage data to guide indication selection and targeted patient populations ...

  45. Dr Madeline Lancaster

    ... pathways can promote or delay fate transitions that guide the production of neurons. We are also exploring the roles of supportive ...

  46. Mr Nick Screaton

    Dr Screaton was appointed Consultant Radiologist in Papworth and Addenbrooke's Hospitals, Cambridge in 2000. He specialises in cardiothoracic radiology and has acted as Radiology Clinical Director in Papworth Hospital 2004 - 12 and President of the...

  47. Dr Phil Jones

    Our group studies how normal cell behaviour is altered by mutation in the early stages of cancer evolution. We focus on squamous tissues, the skin epidermis and the lining of the oesophagus, using transgenic models, novel sequencing approaches in human...

  48. Mr Stephen Price

    My research group is interested in using advanced MRI and PET imaging to study the area around brain tumours with a view to developing improved methods of local control of gliomas. In this 'peritumoural area' is tumour invasion into areas of normal,...

  49. Professor Tom Blundell

    Tom Blundell's research combines structural biology, structural bioinformatics and structure-guided drug discovery. Most of his work has been on multi-component protein assemblies, first focusing on growth factor relationships with receptor tyrosyl...

  50. Miss Ariella Stewart

  51. Dr Andreas Bender

    Previously affiliated with the Lead Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug discovery field in my group with the University of Cambridge. Our expertise ranges...

  52. Miss Alexandra Hart

  53. Dr Aisling Redmond

    Aisling received her undergraduate degree in Genetics from Trinity College Dublin and PhD from Dublin City University. She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK...

  54. Dr Andrew Murray

    Our interest lies in the control of mitochondrial respiration and energy metabolism. We are interested in the metabolic response to dietary manipulation and alterations in oxygen supply, including the matching of oxygen demand and supply. We study this...

  55. Professor Alan Warren

    Our long-term goal is to elucidate the molecular mechanisms of ribosome assembly in eukaryotic cells and to understand how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome,...

  56. Dr Alasdair Russell

    ... ‘Hub’ for the innovation and application of state-of-the-art Genome Editing technologies to complex, patient-relevant model systems in a ...

  57. Dr Christopher Jones

    My research focuses on improving the radiation response and post-radiation monitoring of oesophageal cancers, with a particular focus on ...

  58. Professor Charlotte Coles

    ... best chance of cure with least side effects by personalising radiation techniques based on risk of recurrence. She is Chief Investigator ... Coles is lead for Cancer Research UK Radnet-Cambridge Radiation Research Centre of Excellence . She a National Institute of ...

  59. Ms Ceilidh Welsh

    ... student working with  Cancer Research UK RadNet Cambridge Radiation Research Centre of Excellence. My  area of research looks into the ... prediction of tumour control and normal-tissue toxicity in radiation therapy.  The goal of this project is to develop and test novel ...

  60. Dr David Fernandez-Antoran

    ... behaviours after exposure to different doses of ionising radiation. The final aim of our research is to understand the effects of ionising radiation in tumours and normal tissues and set the basis for designing ...

  61. Dr David Noble

    ... This model will permit calculation of delivered radiation dose and a better understanding of toxicity outcomes. It will also ...

  62. Dr Julian Sale

    My lab is interested in the mechanisms that alleviate arrested DNA replication and the impact their loss has on mutagenesis and on the maintenance of epigenetic memory through the recycling of histones during replication. Replication can be arrested by...

  63. Dr Karen Eley

    Advanced MRI techniques for head and neck cancer and radiation protection ...

  64. Professor Matthew Allen

    My laboratory is interested in preclinical modelling of musculoskeletal cancer, with a particular emphasis on paediatric cancers (such as osteosarcoma, rhabdomyosarcoma and Ewings sarcoma) and adult cancers that spread to bone (such as breast, prostate,...

  65. Mr Paulius Mennea

    ... PhD student working with Cancer Research UK RadNet Cambridge Radiation Research Centre of Excellence. ...

  66. Dr Thankamma Ajithkumar

    ... 2b Study of GC4711 in combination with Stereotactic Body Radiation Therapy (SBRT) in the treatment of unresectable or borderline ...

  67. Dr Andre Neves

    ... cancer diagnosis and for better assessing response to cancer therapy. Currently, I'm planning a first-in-human clinical trial of a novel ...

  68. Dr Richard Benson

    Interests based around improving radiotherapy and chemoradiotherapy in head and neck and urological cancers, develpoing technical radiotherapy and evaluating treatment related toxicity.

  69. Professor Bertie Gottgens

    ... blood stem/progenitor cell populations used in cell and gene therapy protocols. ...

  70. Professor Kevin Brindle

    ... techniques to detect the early responses of tumours to therapy, with a view to translating these into clinical application. This has ...

  71. Dr Camilo Colaco

    Developing cancer therapy as opposed to research. Autologous tumour-dendritic cell fusion hybrids ...

  72. Dr Camilo Colaco

  73. Dr Chiwen Chang

    1. Interaction between NK cells and HLA Class I antigen during immune response. 2. Immunotherapy for cancers and autoimmune diseases.

  74. Dr Claire Connell

    Pancreatic cancer and immunotherapy

  75. Dr Harry Bulstrode

    ... population. I hold an Academic Clinical Lecturer post in Neurosurgery at the University of Cambridge, combining clinical training at ...

  76. Mr Richard Mair

    My research is focused on the interaction between the microenvironment and genome and how this comes to define brain tumours. I am using novel and ...

  77. Dr Ashray Gunjur

    I am an early-career medical oncologist from Melbourne, Australia. I am broadly interested in ...

  78. Dr Fiona Harris

    Consultant Clinical Oncologist, Consultant in CNS tumours, TYA lead, CNS tumours in both the adult ...

  79. Dr Fazlur Rahman Talukdar

    ... of early cancer detection and monitoring. I am a molecular oncologist and I earned my PhD from Assam University in India, where I focused ...

  80. Dr Kate Fife

    Dr Kate Fife is a consultant clinical oncologist at Addenbrooke's Hospital, Cambridge where she was appointed in ...

  81. Professor Richard Gilbertson

    ... of Excellence. Richard Gilbertson trained as a pediatric oncologist in the UK where he earned his MBBS and PhD degrees, becoming a ...

  82. Dr Robert Thomas

    An oncologist specialising in breast, colon and urological cancers, including the ...

  83. Dr Simon Pacey

    As a Medical Oncologist trained in early drug development, my research interests are: Early ...

  84. Dr Susan Galbraith

    UK trained Clinical Oncologist PhD in Oncology - Vascular Targeting Agents - endothelial cell ...

  85. Dr Ahsan MEMON

    ... cell behaviours through cell signaling. Ever since, these findings have directly led to expanding and redefining understanding of ... modulator to generate multi-depth multi-chromatic holograms. These holograms are produced through a custom-developed iterative code with ...

  86. Professor Anna Philpott

    ... a disease of differentiation. Ultimately, our studies on these fundamental mechanisms that co-ordinate proliferation and differentiation ...

  87. Dr Alex Cagan

    ... our own bodies are constantly acquiring mutations. Some of these mutations may influence cellular phenotypes, such as growth, resulting in ... Over time our bodies become a patchwork of clones. These processes drive cancer progression and may contribute to ageing.  Due to ...

  88. Professor Ben Simons

    ... epidermal maintenance in mouse. Currently, we are extending these ideas to explore cell fate in human epidermis addressing both normal and malignant tissue. These investigations are pursued in close collaboration with experimentalists ...

  89. Dr Basma Greef

    ... of hypoxia response pathways in renal cancer and how these can be harnessed to develop new treatments. My other interests include ...

Pages